KOSDAQ150 Index Rebalance Preview (June): Changes Keep Rolling In
Early in the review period, we see 9 potential changes for the KOSDAQ150 in June. The potential adds have outperformed the potential deletes by a...
824 Views
EuBiologics (206650 KS): Base Business Recovery; COVID Vaccine Undergoing Phase 3 Trial
EuBiologics has bagged contract to supply 67.1 million doses of oral cholera vaccine to UNICEF. Its COVID-19 vaccine candidate is undergoing phase...
563 Views
KOSDAQ150 Index Rebalance Preview: 15 Potential Changes and Large Turnover
At the end of the review period, we see 15 potential changes for the KOSDAQ150 index. Most of the changes are high probability. The adds could...
888 Views
KOSDAQ150 Index Rebalance: Green Cross Merger & EuBiologics Addition
EuBiologics will be added to the KOSDAQ150 Index at the close on 27 Oct due to the Green Cross merger. We would look to be long EuBio for the next...
599 Views
EuBiologics (206650 KS): Cashing on Vaccine Business
Eubiologics is on a stable growth path, driven by increasing demand of its oral cholera vaccine business. Upcoming commercialization of COVID-19...
987 Views